ClearPoint Neuro (CLPT) Operating Expenses (2011 - 2026)

ClearPoint Neuro (CLPT) has 15 years of Operating Expenses data on file, last reported at $11.7 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 47.95% year-over-year to $11.7 million; the trailing twelve-month figure through Mar 2026 stood at $37.6 million (up 29.96% YoY), and the FY2025 full-year result was $33.0 million, up 24.54% from the prior year.
• Operating Expenses grew to $11.7 million in Q1 2026, from $11.2 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $11.7 million in Q1 2026 to a low of $4.8 million in Q3 2022.
• A 5-year average of $6.9 million and a median of $6.1 million in 2024 frame the typical range for Operating Expenses.
• Peak annual rise in Operating Expenses reached 57.67% in 2022, while the deepest fall reached 20.29% in 2022.
• Tracing CLPT's Operating Expenses over 5 years: stood at $4.9 million in 2022, then gained by 23.61% to $6.1 million in 2023, then surged by 43.05% to $8.7 million in 2024, then increased by 29.54% to $11.2 million in 2025, then rose by 4.17% to $11.7 million in 2026.
• Business Quant data shows CLPT's Operating Expenses at $11.7 million in Q1 2026, $11.2 million in Q4 2025, and $7.4 million in Q3 2025.